alpha-human Dectin-1-Pam3 conjugate (Dynavax Technologies)

N/A

Report date: 2025/03/14 16:20:28

Base Information

Drug Namealpha-human Dectin-1-Pam3 conjugate (Dynavax Technologies)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionC-type lectin domain family 7 member A stimulants
TargetsC-type lectin domain family 7 member A
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDynavax Technologies Corp
China Registration ClassN/A

Develop Information

Active CompaniesDynavax Technologies Corp
Inactive CompaniesN/A
Active IndicationsInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A